Gts Securities LLC Arbutus Biopharma Corp Transaction History

Gts Securities LLC

  • $2.24 Trillion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$3.12 - $4.56 $89,909 - $131,405
28,817 New
28,817 $110,000
Q1 2024

May 15, 2024
BUY
$2.26 - $2.92 $42,194 - $54,516
18,670 Added 59.38%
50,110 $129,000
Q4 2023

Feb 14, 2024
BUY
$1.69 - $2.54 $53,133 - $79,857
31,440 New
31,440 $78,000

Others Institutions Holding ABUS

# of Institutions
189
Shares Held
112M
Call Options Held
861K
Put Options Held
708K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $510M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email